Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects
- PMID: 22091
- DOI: 10.1007/BF00426775
Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects
Abstract
The hallucinogenic substance N',N'-dimethyltryptamine and its precursor N-methyltryptamine were found in 24-h specimens of urine from 19 normal human subjects; the mean excretion rates were 386 ng 24 h(-1) and 856 ng 24 h(-1) respectively. The urinary excretion of both compounds was unrelated to age, sex, urinary volume, or creatinine, nor was any consistent diurnal pattern observed. Rates for the mono and dimethylated compounds were not correlated. Diet and the intestinal flora were excluded as a source of urinary dimethyltryptamine. Administration to 4 subjects of sufficient ammonium chloride to increase the H ion concentration of the urine caused a transient increase in dimethyltryptamine excretion but no consistent increase in the rate for N-methyltryptamine. Acidification of the urine did not appear to be the determining factor in this result since in one subject the same drop in urinary pH was achieved by feeding methionine without any increase in dimethyltryptamine excretion.
Similar articles
-
Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.Arch Gen Psychiatry. 1979 Jun;36(6):644-9. doi: 10.1001/archpsyc.1979.01780060034003. Arch Gen Psychiatry. 1979. PMID: 286576
-
Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.Can Psychiatr Assoc J. 1976 Dec;21(8):541-6. doi: 10.1177/070674377602100808. Can Psychiatr Assoc J. 1976. PMID: 1071579 No abstract available.
-
A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.Br J Psychiatry. 1980 Sep;137:236-9. doi: 10.1192/bjp.137.3.236. Br J Psychiatry. 1980. PMID: 6777009
-
A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances.Schizophr Bull. 1976;2(1):90-105. doi: 10.1093/schbul/2.1.90. Schizophr Bull. 1976. PMID: 779022 Review. No abstract available.
-
N, N-dimethyltryptamine: an endogenous hallucinogen.Int Rev Neurobiol. 1981;22:83-110. doi: 10.1016/s0074-7742(08)60291-3. Int Rev Neurobiol. 1981. PMID: 6792104 Review. No abstract available.
Cited by
-
On the physiology of metazoa.Experientia. 1996 Mar 15;52(3):189-211. doi: 10.1007/BF01920707. Experientia. 1996. PMID: 8631386 Review.
-
Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.Curr Drug Metab. 2010 Oct;11(8):659-66. doi: 10.2174/138920010794233495. Curr Drug Metab. 2010. PMID: 20942780 Free PMC article. Review.
-
Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.Psychopharmacology (Berl). 1979 Apr 25;62(3):207-10. doi: 10.1007/BF00431949. Psychopharmacology (Berl). 1979. PMID: 111285
-
Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.Biochemistry. 2014 May 13;53(18):2956-65. doi: 10.1021/bi500175p. Epub 2014 Apr 28. Biochemistry. 2014. PMID: 24730580 Free PMC article.
-
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.J Neural Transm (Vienna). 2009 Dec;116(12):1591-9. doi: 10.1007/s00702-009-0308-8. Epub 2009 Sep 12. J Neural Transm (Vienna). 2009. PMID: 19756361
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources